Notes to Accounts of Coral Laboratories Ltd.

Mar 31, 2018

Note 1: Company Information:

Coral Laboratories Limited is a public limited company domiciled in India and is listed on Bombay Stock Exchange (BSE). The company is engaged in manufacturing of Pharmaceutical formulations. Company''s manufacturing facilities are located at Daman and Dehradoon and corporate office is located at Mumbai. The Registered office of the company is situated at SF-206, silver oak complex, BTC Road, Vadodara 390020.

Terms and rights attached to equity shares

The Company has only one class of equity shares having face value of 10 each. Each holder of Equity share is entitled to one vote per share.

In the event of liquidation of the Company, the holders of the equity shares will be entitled to receive remaining assets of the Company.

The distribution will be in proportion to the number of equity shares held by the shareholders.

The Board of Directors has recommended dividend of 2 per Equity share of 10/- each subject to the shareholders approval in the ensuing 36th Annual General Meeting.

This information as required to be disclosed under the Micro, Small and Medium Enterprises Development Act, 2006 (MSMED) has been determined to the extent such parties have been identified on the basis of information available with the company and relied by the auditors.

Defined contribution plans

The Company makes Provident Fund and Employee State Insurance Contributions to defined contribution plans for qualifying employees. Contribution are made to provident fund in India for employees at the rate of 12% of basic salary as per regulations. The contribution are made to registered provident fund administered by the government. The obligation of the Company is limited to the amount contributed and it has no further contractual nor any constructive obligation.

The Company recognised year ended 31st March 2018 Rs. 20.12 lakhs ( Year ended 31st March, 2017 Rs.18.39 lakhs) for Provident Fund contributions and Rs.5.27 lakhs (Year ended 31st March, 2017 Rs.3.32 lakhs) for employee State Insurance contributions in the Statement of Profit and Loss.

Defined benefit plans

Gratuity

The Company provides for gratuity for employees in India as per the Payment of Gratuity Act, 1972. Employees who are in continuous service for a period of 5 years are eligible for gratuity. Every employee is entitled to a benefit equivalent to fifteen days salary last drawn for each completed year of service in line with the Payment of Gratuity Act, 1972 or Company scheme whichever is beneficial. The same is payable at the time of separation from the Company or retirement, whichever is earlier. The benefits vest after five years of continuous service.

(ii) Fair value hierarchy

This section explains the judgements and estimates made in determining the fair values of the financial instruments that are (a) recognised and measured at fair value and (b) measured at amortised cost and for which fair values are disclosed in the financial statements. To provide an indication about the reliability of the inputs used in determining fair value, the Company has classified its financial instruments into the three levels prescribed under the accounting standard. An explanation of each level follows underneath the table.

The fair value of financial instruments as referred to in note above has been classified into three categories depending on the inputs used in the valuation technique. The hierarchy gives the highest priority to quoted prices in active market for identical assets or liabilities (level 1 measurement) and lowest priority to unobservable inputs (level 3 measurements). The categories used are as follows:

Level 1 : Financial instruments measured using quoted prices. This includes listed equity instruments, traded bonds, mutual funds, bonds and debentures, that have quoted price. The fair value of all equity instruments (including bonds) which are traded in the stock exchanges is valued using the closing price as at the reporting period.

Level 2: The fair value of financial instruments that are not traded in an active market (for example, over-the-counter derivatives) is determined using valuation techniques which maximise the use of observable market data and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is considered here. For example, the fair value of forward exchange contracts, currency swaps and interest rate swaps is determined by discounting estimated future cash flows using a risk-free interest rate. The mutual funds are valued using the closing NAV published by mutual fund.

Level 3: The fair value of financial instruments that are measured on the basis of entity specific valuations using inputs that are not based on observable market data (unobservable inputs). When the fair value of unquoted instruments cannot be measured with sufficient reliability, the Company carries such instruments at cost less impairment, if applicable.

The carrying amounts of trade receivables, trade payables, cash and cash equivalents and other bank balances, loans and other financial liabilities are considered to be the same as their fair values due to their short-term nature. The carrying amount of long term borrowings are considered to be same as their fair values, as these borrowings carry floating interest rates.

Note 2 - Financial Risk Management

The Company''s business activities expose it to a variety of financial risks, namely liquidity risk, market risks and credit risk. The Company''s senior management has overall responsibility for the establishment and oversight of the Company''s risk management framework. The Company has constituted a Risk Management framework, through which management develops and monitors the Company''s risk management policies. The key risks and mitigating actions are also placed before the Board of directors of the Company. The Company''s risk management policies are established to identify and analyse the risks faced by the Company, to set appropriate risk limits and controls and to monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly to refect changes in market conditions and the Company''s activities.

“The Risk Management Framework of the Company is enforced by the finance team and experts of business division that provides assurance that the Company''s financial risk activities are governed by appropriate policies and procedures and that financial risks are identified, measured and managed in accordance with the Company''s policies and risk objectives. The activities are designed to: -

protect the Company''s financial results and position from financial risks; -

maintain market risks within acceptable parameters, while optimising returns; and

The finance department is responsible to maximise the return on companies internally generated funds.”

“The note explains the Company''s exposure to financial risks and how these risks could affect the Company''s future financial performance.”

(A) Credit Risk

Credit risk arises from the possibility that the counter party may not be able to settle their obligations as agreed. Credit risks from balances with banks and financial institutions are managed in accordance with the Company''s policy. For derivative and financial instruments, the Company attempts to limit the credit risk by only dealing with reputable banks and financial institutions having high credit ratings assigned by the credit rating agencies. The Company periodically assesses financial reliability of customers and other counter parties, taking into account the financial condition, current economic trends, and analysis of historical bad debts and ageing of financial assets. Individual risk limits are set and periodically reviewed on the basis of such information.

The Company considers the probability of default upon initial recognition of asset and whether there has been a significant increase in credit risk on an ongoing basis throughout each reporting period. To assess whether there is a significant increase in credit risk the Company compares the risk of a default occurring on the asset as at the reporting date with the risk of default as at the date of initial recognition. It considers available reasonable and supportive forwarding-looking information. The outstanding trade receivables are regularly monitored and appropriate action is taken for collection of overdue receivables.

In respect of its investments the company aims to minimize its financial credit risk through the application of risk management policies.

The gross carrying amount of trade receivables is INR 3161.25 Lakhs (March 31, 2017: INR 3063.74 Lakhs, April 1, 2016: INR 2780.72 Lakhs)

The Company maintains exposure in cash and cash equivalents, term deposits with banks, Loans, Security deposits and other financial assets.

Other advances are given for trade purpose which is in line with normal business activities of the Company . Provision is taken on a case to case basis depending on circumstances with respect to non recoverability of the amount. The gross carrying amount of such loans and advances is INR 934.08 lakhs (March 31, 2017: INR 859.80 Lakhs, April 1, 2016: INR 905.35 Lakhs)

(B) Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. The Company''s approach for managing liquidity is to ensure that it will have sufficient liquidity to meet its liabilities when they are due, under both normal and stressed conditions, without incurring unacceptable losses or risking manage to Company''s reputation. In addition, processes and policies related to such risks are overseen by the senior management. The management monitors the Company''s net liquidity position through rolling forecasts on the basis of expected cash flows.

(c) Market risk

The Company is exposed to risk from movements in foreign currency exchange rates, interest rates and market prices that affect its assets, liabilities and future transactions.

(i) Foreign exchange risk

Foreign currency risk is that risk in which the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. The Company operates internationally and a portion of its business is transacted in multiple currencies and therefore the Company is exposed to foreign exchange risk through its overseas sales and purchases in various foreign currencies. The Company takes decision to hedge by forming view after discussions with it''s advisors and as per policies set by Management.

The Company was also exposed to the foreign currency loans availed from banks to reduce the overall interest cost. The Company had fully hedged loan exposure in foreign currency to mitigate the foreign exchange risk on the same.

Foreign exchange derivatives and exposures outstanding as at Balance Sheet date

(ii) Interest rate risk

Interest rate risk is the risk that the fair value of future cash flows of the financial instruments will fluctuate because of changes in market interest rates.

The Company borrows at variable as well as fixed interest rates and the same is managed by the Company by constantly monitoring the trends and expectations. In order to reduce the overall interest cost, the Company has borrowed in a mix of short term and long term loans.

(D) Price Risk

The Company''s exposure to equity securities price risk arises from investments held by the Company and classified in the balance sheet either as fair value through OCI.

To manage its price risk arising from investments in equity securities, the Company diversifies its portfolio.

Note 3 - Capital management

(a) Risk Managements

The Company aim to manage its capital efficiently so as to safeguard its ability to continue as a going concern and to optimise returns to its shareholders.

The Company''s capital management is driven by Company''s policy to maintain a sound capital base to support the continued development of its business. The Board of Directors seeks to maintain a prudent balance between different components of the Company''s capital. The Management monitors the capital structure and the net financial debt at individual currency level. Net financial debt is defined as current and non-current financial liabilities less cash and cash equivalents and short-term investments.

The Company''s policy is to maintain a stable and strong capital structure with a focus on total equity so as to maintain investor, creditors and market confidence and to sustain future development and growth of its business. The Company will take appropriate steps in order to maintain, or if necessary adjust, its capital structure.

The debt equity ratio highlights the ability of a business to repay its debts.

The company has ongoing litigations related to central excise and service tax. The company has not disclosed the same as contingent liability considering the remote possibility of outflow of resources embodying economic benefits based on judgements received in favour of the company in past years.

Note 4 - Segment information

“Operating Segments are reported in a manner consistent with the internal reporting provided to the Chief operating decision maker ("CODM") of the Group. The CODM who is responsible for allocating resources and assessing performance of the operating segments has been identified as the Chairman and Managing Director.

The Group operates only in one business segment i.e. "Manufacturing & Sale of Pharmaceutical products" which is reviewed by CODM. The CODM examine the group performance from a geographic perspective and has identified two of its following business as identifiable segments:"

a) Ethopia

b) India

c) Rest of World

Note 5 - First-time adoption of Ind AS Transition to Ind AS

The accounting policies set out in Note 2 have been applied in preparing the financial statements for the year ended 31 March 2018, the comparative information presented in these financial statements for the year ended 31st March, 2017 and in the preparation of an opening Ind AS balance sheet at 1st April, 2016 (the Company''s date of transition). In preparing its opening Ind AS balance sheet, the Company has adjusted the amounts reported previously in financial statements prepared in accordance with the accounting standards notified under Companies (Accounting Standards) Rules, 2006 (as amended) and other relevant provisions of the Act (previous GAAP or Indian GAAP or IGAAP). An explanation of how the transition from previous GAAP to Ind AS has affected the Company''s financial position, financial performance and cash flows is set out in the following tables and notes.

A.1 Exemptions and exceptions availed

Set out below are the applicable Ind AS 101 optional exemptions and mandatory exceptions applied in the transition from previous GAAP to Ind AS.

Ind AS optional Exemptions A.1.1 Deemed cost

Ind AS 101 permits a first-time adopter to elect to continue with the carrying value for all of its property, plant and equipment (including capital work-in-progress) as recognised in the financial statements as at the date of transition to Ind AS, measured as per the previous GAAP and use that as its deemed cost as at the date of transition after making necessary adjustments for decommissioning liabilities, capital grant if applicable. This exemption can also be used for intangible assets covered by Ind AS 38 Intangible Assets.

Accordingly, the Company has elected to measure all of its property, plant and equipment and intangible assets at their previous GAAP carrying value.

A.2 Ind AS mandatory exceptions

The Company has applied the following exceptions from full retrospective application of Ind AS as mandatorily required under Ind AS 101:

A.2.1 Estimates

An entity''s estimates in accordance with Ind AS at the date of transition to Ind AS shall be consistent with estimates made for the same date in accordance with previous GAAP (after adjustments to refect any difference in accounting policies), unless there is objective evidence that those estimates were in error. I nd AS estimates as at 1 April 2016 are consistent with the estimates as at the same date made in conformity with previous GAAP The Company made estimates for following items in accordance with Ind AS at the date of transition as these were not required under Previous GAAP

1) Investments in Equity Instruments carried at FVTPL or FVOCI.

2)Impairment of Financial Assets based on expected credit loss model.

A.2.2. Classification and Measurement of financial Assets

Ind AS 101 requires an entity to assess classification and measurement of financial assets on the basis of the facts and circumstances that exist at the date of transition to Ind AS.

B: Reconciliations between previous GAAP and Ind AS

Ind AS 101 requires a first time adopter to reconcile equity, total comprehensive income and cash flows for prior periods. The following tables represent the reconciliations from previous GAAP to Ind AS. The presentation requirements under previous GAAP differs from and hence the previous GAAP information has been restated for ease of reconciliation with Ind AS.

The restated previous GAAP information is derived based on the audited financial statements of the company for the year ended 31st March, 2017 and 1st April, 2016.

The following reconciliations provide a quantification of the effect of significant differences arising from the transition from previous GAAP to Ind AS in accordance with Ind AS 101:

Reconciliation of Balance Sheet as at April 1, 2016 (Transition Date)

Reconciliation of Balance Sheet as at March 31, 2017 and reconciliation of Statement of Total Comprehensive Income for the year ended March 31, 2017

The presentation requirements under previous GAAP differs from Ind AS and hence previous GAAP information has been regrouped for inline with Ind AS. The regrouped previous GAAP information is derived from the Financial Statements of the Group prepared in accordance with the previous GAAP

There is insignificant change in the net cash flow from operating, investing or financing activities due to Ind AS adoption. Further, there is no change in the cash and cash equivalents for the purposes of statement of cash flows under previous GAAP and under Ind AS

C: Notes to first-time adoption:

Note C-1: Remeasurements of post-employment benefit obligations

Under Ind AS, remeasurements i.e. actuarial gains and losses and the return on plan assets, excluding amounts included in the net interest expense on the net defined benefit liability are recognised in other comprehensive income instead of profit or loss. Under the previous GAAP these remeasurements were forming part of the profit or loss for the year.

Note C-2: Excise duty and Goods and Service Tax

Under previous GAAP revenue from sale of products was presented exclusive of excise duty. Under Ind AS, revenue from sale of goods is presented inclusive of excise duty. The excise duty paid is presented on the face of the statement of profit and loss as part of expense.

Consequent to introduction of Goods and Service tax (GST) with effect from July 01, 2017, Central Excise, Service Tax, Value Added Tax (VAT) etc. have been subsumed into GST In accordance with Indian Accounting Standard and Schedule III of the Companies Act, 2013, GST is not included in Revenue from operations. In view of the aforesaid restructuring of indirect taxes, Revenue from operations and Excise duty for the year ended March 31, 2018 are not comparable with the previous year.

Note C-3: Proposed dividend

Under previous GAAP dividends on equity shares recommended by the Board of Directors after the end of the reporting period but before the financial statement were approved for issue were recognised in the financial statement as a liability. Under Ind AS, such dividends are recognised when declared by the members in the general meeting.

Note C-4: Investments

"Under the previous GAAP investments in equity instruments were classified as long-term investments or current investments based on the intended holding period and realisability. Long-term investments were carried at cost less provision for other than temporary decline in the value of such investments. Current investments were carried at lower of cost and fair value. Under IND AS, these investments are required to be measured at fair value. Fair value changes with respect to investments in equity instruments designated as FVOCI have been recognised in FVOCI - Equity investments reserve as at the date of transition and subsequently in the Other Comprehensive Income for the year ended March 31, 2017."

Note C-5: Other comprehensive income

The concept of other comprehensive income did not exist under previous GAAP Under Ind AS, all items of income and expense recognised in a period should be included in profit or loss for the period, unless a standard requires or permits otherwise. Items of income and expense that are not recognised in profit or loss but are shown in the statement of profit and loss as ‘other comprehensive income'' includes remeasurements of defined benefit plans and related tax impact.

Note 6: Comparative figures

The previous years'' figures have been regrouped / re-arranged, where necessary, to conform to the current year''s disclosures/presentations.

---

Mar 31, 2016

A. Terms & Rights attached to equity shares:

The Company has only one class of equity shares having face value of Rs.10 each. Each shareholder of Equity share is entitled to one vote per share. The dividend proposed by the board of directors is subject to the approval of the shareholders in the ensuing annual general meeting.

In the event of Liquidation of the company, shareholders of the equity shares will be entitled to receive remaining assets of the company, after distribution of Preferential amount. The distribution will be in proportion to the Number of equity shares held by Shareholders.

iv The company has proposed dividend of Rs. 10,717,800/v The accounts of debtors, creditors & advances are subject to confirmation/reconciliation. The management does not expect any material difference affecting the financial statements on reconciliation/adjustments.

vi In the opinion of the board, the Current Assets, Loans and advances have a value on realization in the ordinary course of business at least equal to the amount at which they are stated.

vii Figures of the previous year has been re-grouped, recast or rearranged wherever considered necessary to make them comparable with that of the current year.

---

Mar 31, 2015

Note 1: Company Information:

Coral Laboratories Limited is a public limited company domiciled in India and is listed on Bombay Stock Exchange (BSE). The company is engaged in manufacturing of Pharmaceutical formulations. Company''s manufacturing facilities are located at Daman and Dehradoon and corporate office is located at Mumbai.

2 Contingent liabilities and commitments (to the extent not provided for)

Particulars As at 31st March 2015 As at 31st March 2014

(i) Contingent Liabilities Nil Nil

(ii) Commitments Nil Nil

3 Related Party Disclosure

Related party Disclosures as required by AS-18," Related Party Disclosures", are given below:

A. Key Management Personnel

Name Designation

Mr. Navin B Doshi Chairman

Mr. Priyush R Dhedhi Director

Mr. K R Mehta Whole Time Director

Mr. Rajesh R Parikh Director

Mrs. Sheela Kamdar Director

B. Relatives of key management personnel and Enterprises over which key management personnel and their relatives are able to exercise significant influence are as follows:

Name Designation

Coral India Finance and Housing Ltd Significant Influence

Adore Pharmaceuticals Private Ltd Significant Influence

Mr. Chetan Navin Doshi Relative of Key Management Personnel

Mrs. Meeta Samir Sheth Relative of Key Management Personnel

4 Other Notes on Accounts

i Demand of Rs. 18.56 Lacs is raised by the Central Excise & Customs, Vadodara in pursuance of order under section 11A of Central Excise Act, 1944. The Company has preferred an appeal to the Supreme Court of India against the same.

ii Company''s Baroda Plant was not in operation.

iii Prior Period expenditure is Rs. 45,815/- (Previous year Rs. 219,532/-)

iv The company has proposed dividend of Rs. 8,931,500/-

v The accounts of debtors, creditors & advances are subject to confirmation/reconciliation. The management does not expect any material difference affecting the financial statements on reconciliation/adjustments.

vi In the opinion of the board, the Current Assets, Loans and advances have a value on realisation in the ordinary course of business atleast equal to the amount at which they are stated.

vii Figures of the previous year has been re-grouped, recast or rearranged wherever considered necessary to make them comparable with thatofthecurrentyear.

---

Mar 31, 2014

NOTE 1 : COMPANY INFORMATION:

Coral Laboratories Limited is a public limited company domiciled in India and is listed on Bombay Stock Exchange (BSE). The company is engaged in manufacturing of Pharmaceutical formulations. Company''s manufacturing facilities are located at Daman and Dehradoon and Corporate office is located at Mumbai.

2. Contingent liabilities and commitments (to the extent not provided for)

Particulars As at 31st March 2014 As at 31st March 2013

(i) Contingent Nil Nil Liabilities

(ii) Commitments Nil Nil

3. Other Notes on Accounts

i Demand of 18.56 Lacs is raised by the Central Excise & Customs, Vadodara in pursuance of order under section 11A of Central Excise Act, 1944. The Company has preferred an appeal to the Supreme Court of India against the same.

ii Company''s Baroda Plant was not in operation.

iii Prior Period expenditure is 219,532/- (Previous year 145,452/-)

iv The company has proposed dividend of 7,145,200/- and has transferred 6,000,000/-to general reserve.

v The accounts of debtors, creditors & advances are subject to confirmation/reconciliation. The management does not expect any material difference affecting the financial statements on reconciliation/adjustments.

vi In the opinion of the board, the Current Assets, Loans and advances have a value on realisation in the ordinary course of business atleast equal to the amount at which they are stated.

vii Kolkatta office was discontinued during the year and all the balances were transferred to respective locations.

viii Figures of the previous year has been re-grouped, recast or rearrange wherever considered necessary to make them comparable with that of the current year.

---

Mar 31, 2013

NOTE 1 : COMPANY INFORMATION:

Coral Laboratories Limited is a public limited company domiciled in India and is listed on Bombay Stock Exchange (BSE). The company is engaged in manufacturing of Pharmaceutical formulations. Company''s manufacturing facilities are located at Daman and Dehradun and Corporate Office is located at Mumbai.

---

Mar 31, 2012

NOTE 1 : COMPANY INFORMATION:

Coral Laboratories Limited is a public limited company domiciled in India and is listed on Bombay Stock Exchange (BSE). The company is engaged in manufacturing of Pharmaceutical formulations. Company's manufacturing facilities are located at Daman and Dehradun and Corporate Office is located at Mumbai.

A. Terms & Rights attached to equity shares:

The Company has only one class of equity shares having face value of Rs. 10 each. Each shareholder of Equity share is entitled to one vote per share. The dividend proposed by the board of directors is subject to the approval of the shareholders in the ensuing annual general meeting.

In the event of Liquidation of the company, the shareholders of the equity shares will be entiltled to receive remaining assets of the company, after distribution of Preferential amount. The distribution will be in proportion to the Number of equity shares held by Shareholders.

Security Details:

Primary Security - Secured against hypothecation of entire current assets and movable fixed assets of the company and FDR for margins. Collateral Security - Equitable mortgage of Plot No. 27 & 28, Industrial Area, Pharmacity, Selaqui, Chakrata Road, Dehradoon, Uttaranchal and Office unit located at 503, 5th floor, Dalamal House, Nariman Point, Mumbai.

Sundry creditors of Rs. 92.22 lacs are outstanding to Micro and Small Enterprises (on the basis of information available with the company). Interest if any payable on delayed payment to Micro and Small Enterprises under Micro, and Small and medium enterprises development Act., 2006 is not ascertainable.

2 Contingent liabilities and commitments (to the extent not provided for)

Particulars As at 31st March 2012 As at 31st March 2011

(i) Contingent Liabilities Nil Nil

(ii) Commitments Nil Nil

3 Other Notes on Accounts

i The Central Excise & Customs, Service Tax Cell have raised a notice for the purpose of depositing service tax for the period 16.11.1997 to 01.06.1998 for Goods Transport Operators' service provided. The Company has filed appeal against the same.

ii Demand of Rs. 18.56 Lacs is raised by the Central Excise & Customs, Vadodara in pursuance of order under section 11A of Central Excise Act, 1944. The Company has preferred an appeal to the Supreme Court of India against the same.

iii Demand of Rs. 1,74,363/- is raised by Deputy Commissioner, Dehradoon pursuant to the order passed under section 9(2) of The Sales Tax Act for FY 2007-08. The company has been advised to file the appeal against the same order before appellate authority.

iv Company's Baroda Plant was not in operation.

v Prior Period expenditure is Rs. 346,379/- (Previous year Rs. 160,841/-)

vi The company has proposed dividend of Rs. 53,58,900/- and has transferred Rs. 35,00,000/- to general reserve.

vii The accounts of debtors, creditors & advances are subject to confirmation/reconciliation. The management does not expect any material difference affecting the financial statements on reconciliation/adjustments.

viii In the opinion of the board, the Current Assets, Loans and advances have a value on realisation in the ordinary course of business atleast equal to the amount at which they are stated.

ix Financial statements have been prepared in accordance with revised schedule VI of the Company's Act. Accordingly figures of the previous year has been re-grouped, recast or rearranged wherever considered necessary to make them comparable with that of the current year.

---

Mar 31, 2010

1) The Central Excise & Customs, Service Tax Cell have raised a notice for the purpose of depositing service tax for the period 16.11.1997 to 01.06.1998 for Goods Transport Operators service provided. The Company has filed appeal against the same.

2) Demand of Rs. 18.56 Lacs is raised by the Central Excise & Customs, Vadodara in pursuance of order under section 11A of Central Excise Act, 1944. The Company has preferred an appeal to the Supreme Court of India against the same.

3) The Income Tax Department has raised a demand of Rs.3.81 lacs for the Assessment Year 2004-05. Income tax department has preferred an appeal in Income Tax Appellate Tribunal, Mumbai.

4) Companys Baroda Plant was not in operation.

5) Company has not included Excise Duty in stock of Raw Material and Packing Material to comply with the AS - 2. The same is reduced from purchases. However, this has no effect on the profit of the Company.

6) Capital commitment not provided for Rs Nil. (Previous Year Rs. 17.72 lacs)

7) Sundry creditors of Rs. 28.47 lacs are outstanding to Micro and Small Enterprises (on the basis of information available with the company). Interest if any payable on delayed payment to Micro and Small Enterprises under Micro, and Small and medium enterprises development Act., 2006 is not ascertainable.

8) The accounts of debtors, Creditors and Advances are subject to confirmation/ reconciliation. The management does not expect any material difference affecting the financial statements on reconciliation/adjustments.

9) In the opinion of the Board, Current Assets, Loans and Advances have a value on realisation in the ordinary course of business at least equal to the amount at which they are stated.

10) Figures of the previous year have been regrouped and/or recast wherever considered necessary.